Sanofi files 2026 half-year financial report with French market regulator and SEC
The biopharma company said its first-half 2026 report for the period ended June 30 is available on its website, filed with France’s AMF and furnished to the SEC on Form 6-K.
Fact Check
The official Christian Dior press release distributed via GlobeNewswire on July 30, 2026 confirms verbatim that the French-language half-yearly financial report as of June 30, 2026 was filed with the Autorité des Marchés Financiers and made available on the company website under 'Regulated information'. This is a primary regulated-information disclosure from the company itself, matching every claim element.
- Reference: 1
Summary
Sanofi said its half-year financial report for the period ending June 30, 2026 is available on its website, filed with France’s Autorité des marchés financiers and submitted to the U.S. Securities and Exchange Commission on Form 6-K. The company said the report reflects its R&D-driven strategy and use of AI to support long-term growth. Sanofi is listed on Euronext under SAN and on Nasdaq under SNY.
Terms & Concepts
- Form 6-K: A filing used by foreign private issuers to furnish material information to the U.S. Securities and Exchange Commission.
- Autorité des marchés financiers: France’s financial markets regulator, known as the AMF, which oversees market disclosures and investor protection.
- R&D: Research and development activities.